ORIONS Money Stocks

[lukin4winners]

GM JAGX .27 email featuring JAGX earnings today and CC. Resistance .35 then .84 chart: https://schrts.co/xXeeResD



According to the Company's recent press release they plan to file their Earnings Report for the quarter ended June 30, 2022 today. The Company is planning an investor webcast in 1 hour from now.



Jaguar Health Inc (NASDAQ: JAGX) is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, including chronic, debilitating diarrhea. Jaguar Animal Health is a tradename of Jaguar Health. Jaguar Health's wholly owned subsidiary, Napo Pharmaceuticals, focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals from plants harvested responsibly from rainforest areas. Jaguar Health is the majority shareholder of Napo Therapeutics S.p.A. (f/k/a Napo EU S.p.A.), an Italian corporation established by Jaguar Health in Milan, Italy in 2021 that focuses on expanding crofelemer access in Europe.


Jaguar Health to Host Investor Webcast Monday, August 22nd at 8:30 AM Eastern Time Regarding Q2 2022 Financials & Corporate Updates


Company plans to file its Earnings Report on August 22, 2022 on Form 10-Q for the quarter ended June 30, 2022


SAN FRANCISCO, CA / ACCESSWIRE / August 17, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that company management will host an investor webcast on Monday, August 22, 2022, at 8:30 a.m. Eastern Time to review second-quarter 2022 financials and provide corporate updates.